PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 183 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $126,017,000 | +155.6% | 7,004,845 | +1.3% | 0.00% | +100.0% |
| Q1 2020 | $49,309,000 | -69.4% | 6,915,749 | +2.5% | 0.00% | -60.0% |
| Q4 2019 | $161,069,000 | -10.6% | 6,744,941 | +0.4% | 0.01% | -28.6% |
| Q3 2019 | $180,099,000 | +10.9% | 6,715,117 | +12.2% | 0.01% | +16.7% |
| Q2 2019 | $162,396,000 | -19.8% | 5,985,834 | +2.6% | 0.01% | -25.0% |
| Q1 2019 | $202,463,000 | +79.6% | 5,834,684 | +1.1% | 0.01% | +60.0% |
| Q4 2018 | $112,700,000 | -24.7% | 5,773,562 | +2.8% | 0.01% | -16.7% |
| Q3 2018 | $149,615,000 | -30.1% | 5,618,289 | -0.9% | 0.01% | -33.3% |
| Q2 2018 | $214,057,000 | +20.1% | 5,667,354 | +3.8% | 0.01% | +12.5% |
| Q1 2018 | $178,301,000 | -32.0% | 5,459,268 | +1.3% | 0.01% | -27.3% |
| Q4 2017 | $262,297,000 | -7.4% | 5,388,190 | +2.8% | 0.01% | -15.4% |
| Q3 2017 | $283,243,000 | +9.5% | 5,242,316 | +13.8% | 0.01% | 0.0% |
| Q2 2017 | $258,657,000 | +43.0% | 4,604,907 | -0.2% | 0.01% | +44.4% |
| Q1 2017 | $180,855,000 | +82.2% | 4,614,814 | +4.4% | 0.01% | +50.0% |
| Q4 2016 | $99,239,000 | +17.1% | 4,422,394 | +18.5% | 0.01% | +20.0% |
| Q3 2016 | $84,768,000 | -1.2% | 3,732,586 | +2.7% | 0.01% | 0.0% |
| Q2 2016 | $85,756,000 | +20.4% | 3,633,739 | +4.1% | 0.01% | 0.0% |
| Q1 2016 | $71,226,000 | -58.8% | 3,491,453 | +4.0% | 0.01% | -58.3% |
| Q4 2015 | $172,711,000 | +32.2% | 3,356,864 | +9.5% | 0.01% | +140.0% |
| Q3 2015 | $130,672,000 | -3.6% | 3,065,969 | +3.0% | 0.01% | -44.4% |
| Q2 2015 | $135,602,000 | +46.8% | 2,977,002 | +22.3% | 0.01% | +50.0% |
| Q1 2015 | $92,367,000 | +53.8% | 2,433,271 | +14.8% | 0.01% | +50.0% |
| Q4 2014 | $60,052,000 | +42.9% | 2,120,467 | +27.5% | 0.00% | +33.3% |
| Q3 2014 | $42,035,000 | +7.4% | 1,662,770 | +23.9% | 0.00% | 0.0% |
| Q2 2014 | $39,147,000 | +19.2% | 1,341,579 | +5.8% | 0.00% | 0.0% |
| Q1 2014 | $32,842,000 | +30.3% | 1,268,019 | +29.5% | 0.00% | +50.0% |
| Q4 2013 | $25,211,000 | +107.6% | 979,026 | +115.7% | 0.00% | +100.0% |
| Q3 2013 | $12,144,000 | +3340.2% | 453,978 | +3059.0% | 0.00% | – |
| Q2 2013 | $353,000 | – | 14,371 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 270,832 | $6,467,000 | 5.27% |
| Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
| Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
| First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
| Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
| HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |